Serum Vitamin D Levels and Risk of Liver Cancer: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies - July 2020
Nutr Cancer. 2020 Jul 24;1-9. doi: 10.1080/01635581.2020.1797127
Yonggui Zhang 1, Xuefeng Jiang 1, Xiangjun Li 2, Mihnea-Alexandru Găman 3 4, Hamed Kord-Varkaneh 5, Jamal Rahmani 5, Ammar Salehi-Sahlabadi 5, Andrew S Day 6, Yan Xu 1
Items in both categories Liver Cancer and Meta-analysis:
- Deaths from many types of Cancer associated with low vitamin D- review of meta-analyses Sept 2020
- 3X less risk of Liver cancer if more than 30 ng of vitamin D – meta-analysis July 2020
- Liver Cancer 8 percent less likely for every 4 ng higher level of vitamin D – Meta-analysis April 2020
- Liver Cancer – higher risk if poor genes (Vitamin D receptor etc) – meta-analysis Dec 2019
Data regarding the relationship between serum vitamin D levels and the risk of liver cancer are conflicting. Therefore, we performed a systematic review and dose-response meta-analysis of all available data of cohort studies on the association of 25-OH-vitamin-D levels with the risk of hepatocellular carcinoma. We conducted a systematic search in PubMed-MEDLINE, Scopus, Cochrane and Web of Science databases for prospective observational studies conducted on the general population from inception to May 2019. Six studies provided data from 6357 participants.
According to the pooled HR, the subjects with the highest serum concentrations of vitamin D had a 47% lower risk of liver cancer vs. the subjects with the lowest serum concentrations of vitamin D (pooled HR: 0.53, 95% CI: 0.41-0.68; P < 0.001). There was no significant heterogeneity among the studies (P = 0.431, I2 = 0.0). The pooled HR from the random-effects dose-response model indicated an indirect significant linear association between vitamin D and the risk of liver cancer (coef = -0.017, P < 0.001). However, there was no significant nonlinear dose-response association between serum vitamin D and the risk of liver cancer (coef = -0.0001, P = 0.342). The evidence from this meta-analysis suggests that there may be an inverse relationship between serum vitamin D levels and the risk of liver cancer.
Dietary and circulating vitamin D and risk of renal cell carcinoma: a meta-analysis of observational studies - Nov 2020
International Braz J Urol: Official Journal of the Brazilian Society of Urology 2020 November 4, 47
Jing Wu, Nan Yang, Mingxin Yuan
Download the PDF from VitaminDWiki
OBJECTIVE: This meta-analysis is the first to evaluate the associations of circulating and dietary intake of vitamin D with risk of risk of renal cell carcinoma (RCC). Our findings showed that higher circulating vitamin D level and dietary vitamin D intake were associated with a reduced risk of RCC. The possible explanation might be attributed to the anti-inflammatory effect, inhibiting cell proliferation, inducing cell differentiation and apoptosis.
MATERIALS AND METHODS: We searched the MEDLINE, EMBASE, and Scopus databases from their inception points through December 2018 for observational studies. The pooled relative risks (RRs) with corresponding 95% CIs were calculated using random-effects or fixed-effects models. The Newcastle-Ottawa scale was employed to assess the quality of the included studies.
RESULTS: A total of 9 publications were included in this meta-analysis. An overall analysis of the highest versus lowest intake levels revealed that circulating vitamin D level was protectively associated with risk of RCC 0.76 (95% CI: 0.64-0.89, P=0.001), with no evidence of heterogeneity (I2=38.8%, P=0.162). In addition, dietary vitamin D intake was associated with a reduced risk of RCC (RR: 0.86; 95% CI: 75-0.99, P=0.030). Statistical heterogeneity was not identified (I2=28.8%, P=0.199). Subgroup analyses results showed the gender differences, and the associations were significant in results with women participants (RR: 0.70; 95% CI: 0.55-0.88) and case-control studies (RR: 0.80, 95% CI: 0.67-0.95).
CONCLUSION: Higher circulating vitamin D level and higher dietary vitamin D intake both might be associated with a reduced risk of RCC. Further high-quality randomized controlled trials are required in the future to confirm our results.
|383 visitors, last modified 08 Nov, 2020,
|14540||renal meta-analysis Nov 2020.pdf||admin 08 Nov, 2020 14:38||468.83 Kb||45|
|14086||Risk of LC vs Vitamin D.jpg||admin 28 Jul, 2020 12:35||42.69 Kb||109|
|14085||Liver Cancer risk.jpg||admin 28 Jul, 2020 12:35||41.68 Kb||97|
|14084||Liver Cancer Meta July 2020 sci-hub.pdf||PDF 2020||admin 28 Jul, 2020 12:19||1.02 Mb||104|